"I am here putting my personal experience and few good tips collecting from market wide. I am not responsible for any kind of loss arising out of any information, posts or opinion appearing on this blog. Thank You Friends"

 

LUPIN LAB  MAY HELP TO THIS STOCK


 "GUJARAT THEMIS BIOSYN LTD"

                                                         Gujarat Themis Biosyn Limited

India’s first company to start commercial production of Anti-tuberculosis drug Rifampicin

    

    Incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. Commenced production in August, 1985 by producing Erythromycin and Erythromycin salts and formulations. The Company was taken over during June 1991 by Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug Companies – Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd.. The Company entered into Technical & Financial collaboration with Yuhan Corporation, South Korea. With Yuhan’s know-how, GTBL became India’s first Company to start commercial production of Anti-tuberculosis drug Rifampicin.


                Group Companies

http://www.gtbl.in/group-companies/#
http://www.themismedicare.com/
http://www.yuhan.co.kr/Main/

                   PRODUCTS


1. Rifamycin-S an intermediate for “Rifampicin” on treatment of Tuberculosis (TB)


2. Lovastatin



   Promoter holding 74.99% ( 48.50% Indian and  26.49% foreign  group), company posted 32cr top line and 4.5cr bottom line with 3.12EPS in fy 2014-15.



              ABOUT  FOREIGN PROMOTER GROUP :- YUHAN



After returning from the USA in 1925, Dr. Ilhan New witnessed the hardship in his country under Japanese imperialism. He founded the Yuhan corporation in 1926 with the belief that only healthy people could reclaim their sovereignty and he sought to solve widespread public health problems. Over 80 years, the founding creed to make the best medicines and contribute to public health has been succeeded by us through our intense research and development activities and successful collaboration with multinational pharmaceutical companies. As a result, Yuhan is one of the most respected companies in Korea for 20 consecutive years, according to the annual Korean Management Association Consulting (KMAC) survey. 



  Stock trading only in BSE @ 52/- level, long term investor can buy @ current price and add more in correction (if any) this one stock can give huge profits in portfolio.


52/60 key levels.. one positive news and Gujarat Themis will cross these resistances...


WEBSITE YUHAN HERE

WEBSITE GUJ THEMIS HERE

SHARE HOLDING PATTERN HERE

Before buying a stock take advice from certified person.

Disclosure :- I am holding this company shares.


Post a Comment

 
Top